TP53 and cancer: Thus, TP53 can serve as an effective predictive biomarker to evaluate prognosis and monitor therapeutic responses in various cancers.388 An analysis of over 29,000 cases from the International Agency for Research on Cancer database revealed that TP53 mutations are potential prognostic biomarkers, and can be used to bolster the predictive accuracy of the OS and DFS of cancer patients.389